CD8-Positive T-Lymphocytes

An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade
Cesare Di Nitto, Domenico Ravazza, Ettore Gilardoni, Thomas Look, Miaomiao Sun, Eleonora Prodi, Vlad Moisoiu, Christian Pellegrino, Markus G. Manz, Emanuele Puca, Michael Weller, Tobias Weiss, Dario Neri, Roberto De Luca

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e008504; DOI: 10.1136/jitc-2023-008504
Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLC
Yongyuan Chen, Zheyu Shao, Zhixing Hao, Zhongwei Xin, Xiaoke Chen, Lijian Huang, Di Chen, Mingjie Lin, Qinyuan Liu, Xia Xu, Jinfan Li, Dang Wu, Jun Yan, Ying Chai, Pin Wu

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e007854; DOI: 10.1136/jitc-2023-007854
Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials
Andreas Roller, Iakov I Davydov, Petra C Schwalie, Martha L Serrano-Serrano, Astrid Heller, Nicolas Staedler, Cláudia S Ferreira, Gabriele Dietmann, Irina Klaman, Alberto Valdeolivas, Konstanty Korski, Michael A Cannarile

Journal for ImmunoTherapy of Cancer Apr 2024, 12 (4) e008185; DOI: 10.1136/jitc-2023-008185
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
Vania Lo Presti, Angelo Meringa, Ester Dunnebach, Alice van Velzen, Aida Valera Moreira, Ronald W Stam, Rishi S Kotecha, Anja Krippner-Heidenreich, Olaf T Heidenreich, Maud Plantinga, Annelisa Cornel, Zsolt Sebestyen, Jurgen Kuball, Niek P van Til, S Nierkens

Journal for ImmunoTherapy of Cancer Apr 2024, 12 (4) e008174; DOI: 10.1136/jitc-2023-008174
Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis
Cathrin L C Gudd, Eoin Mitchell, Stephen R Atkinson, Marie-Anne Mawhin, Samra Turajlic, James Larkin, Mark R Thursz, Robert D Goldin, Nick Powell, Charalambos G Antoniades, Kevin J Woollard, Lucia A Possamai, Evangelos Triantafyllou

Journal for ImmunoTherapy of Cancer Apr 2024, 12 (4) e008078; DOI: 10.1136/jitc-2023-008078
RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment
Yuan Meng, Haotian Liu, Haoran Zhu, Wanrong Zhang, Dong Sun, Xuefei Han, Ying Liu, Guangzuo Luo

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e007171; DOI: 10.1136/jitc-2023-007171
rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors
Minji Lee, Sun-Kyoung Im, Seungtae Baek, Mankyu Ji, Miyoung Kim, Eun Ju Lee, Seung Taek Ji, Sara Ferrando-Martinez, Alexandra Wolfarth, Jun-Young Lee, Daeun Kim, Donghoon Choi

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (3) e008001; DOI: 10.1136/jitc-2023-008001
Vaccines for immunoprevention of DNA mismatch repair deficient cancers
Alejandro Hernandez-Sanchez, Mark Grossman, Kevin Yeung, Shizuko S Sei, Steven Lipkin, Matthias Kloor

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004416; DOI: 10.1136/jitc-2021-004416
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy
Grace Heloise Attrill, Carina N Owen, Tasnia Ahmed, Ismael A Vergara, Andrew J Colebatch, Jordan W Conway, Kazi J Nahar, John F Thompson, Ines Pires da Silva, Matteo S Carlino, Alexander M Menzies, Serigne Lo, Umaimainthan Palendira, Richard A Scolyer, Georgina V Long, James S Wilmott

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004771; DOI: 10.1136/jitc-2022-004771
Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression
Tingting Lv, Xiaofeng Xiong, Wei Yan, Mei Liu, Hongwei Xu, Qin He

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004763; DOI: 10.1136/jitc-2022-004763

Main menu

CD8-Positive T-Lymphocytes

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

CD8-Positive T-Lymphocytes

Pages